Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin studies this year.

OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI agent that can act

Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in funding to support its research. The Financial Times today cited sources as saying that Sam Altman is participating in the investment. He previously provided the initial $180 million funding round that helped launch Retro.

OpenAI CEO Sam Altman will brief U.S. officials on super-agents—AI systems set to revolutionize software development, finance, and event planning.

OpenAI CEO Sam Altman suggested Elon Musk cares more about his businesses than he does the country, shortly after he referred to Musk as "the most inspiring entrepreneur of our time."

Musk has raised questions on project Stargate, the $500bn AI project. This lead to a verbal spat between him and Sam Altman.

Elon Musk and OpenAI CEO Sam Altman are fighting on X about Stargate, the infrastructure project to build data centers for OpenAI in the U.S.

President Donald Trump spoke with OpenAI CEO Sam Altman by phone Friday, ahead of the AI infrastructure announcement, CNBC has learned.

SIGN UP for TheStreet’s FREE Daily newsletter 💰💸 Elon Musk has never avoided getting into arguments with other high-profile figures. He’s publicly insulted politicians such as Bernie Sanders and Elizabeth Warren and lashed out at X users with opinions he doesn’t share.

President Donald Trump on Thursday shrugged off an ugly back-and-forth between tech CEOs Elon Musk and Sam Altman that pitted one of Trump’s most visible lieutenants against a key participant in a massive $500 billion AI project Trump announced Tuesday.